Status:
COMPLETED
Comparison for Pethidine Requirement in Patients Received Spinal Morphine 0.2 and 0.3 mg for Post Lobectomy Analgesia
Lead Sponsor:
Mahidol University
Conditions:
Solitary Mass
Lung Diseases
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to evaluate the amount of total pethidine requirement during the 48 hour postoperative period after receiving spinal morphine 0.2 and 0.3 mg.
Detailed Description
Thoracotomy causes severe pain to the patients. Continuous thoracic epidural is a gold standard for postoperative pain. However, it needs skill. There are many alternatives such as spinal morphine, in...
Eligibility Criteria
Inclusion
- Age \> 18 year and \< 70 year
- Patient ASA physical status I-III.
- Scheduled for thoracotomy with lobectomy.
- Can operate a patient-controlled analgesia (PCA) device.
Exclusion
- Known hypersensitivity to morphine or pethidine
- History of bleeding tendency.
- Known case of infection at the back
- Patient refuse for spinal anesthesia
- History of cerebrovascular disease.
- Scheduled for video-assisted thoracoscopic lobectomy.
- Need mechanical ventilatory support during postoperative period
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01236495
Start Date
November 1 2010
End Date
March 1 2012
Last Update
March 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Siriraj Hospital
Bangkok, Thailand, 10700